Polymorphonuclear granulocytes induce myocardial dysfunction during ischemia and in later reperfusion of hearts

C Seligmann1, A Bock, T Leitsch

  • 1Department of Cardiology, University Hospital Benjamin Franklin, Free University of Berlin, D-12200 Berlin, Germany. cseligmann@talknet.de

Insights

Polymorphonuclear granulocytes (PMNs) significantly impair heart function during low-flow ischemia and reperfusion. These white blood cells caused cardiac damage when introduced during ischemia or reperfusion, highlighting their role in myocardial injury.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Ischemia-Reperfusion Injury

Background:

  • Polymorphonuclear granulocytes (PMNs) are implicated in cardiac reperfusion injury.
  • The specific impact of PMNs on myocardial function during low-flow ischemia and their temporal effects during ischemia/reperfusion remain unclear.

Purpose of the Study:

  • To determine if PMNs compromise myocardial function in hearts subjected to low-flow ischemia.
  • To investigate the deleterious effects of PMNs at different time points during ischemia and reperfusion.

Main Methods:

  • Isolated, working guinea pig hearts underwent 30 minutes of low-flow ischemia and reperfusion.
  • Homologous PMNs were administered during ischemia or early reperfusion with thrombin.
  • External heart work recovery (REHW) and PMN retention (PMNR) were measured.
  • The effect of superoxide dismutase (SOD) was evaluated.

Main Results:

  • PMN application significantly reduced myocardial function (REHW) regardless of administration timing.
  • Intracoronary PMN retention (PMNR) was elevated compared to controls.
  • Superoxide dismutase (SOD) significantly improved REHW but did not alter PMNR.

Conclusions:

  • Thrombin-stimulated PMNs significantly impair cardiac function in low-flow ischemic conditions.
  • PMNs contribute to myocardial dysfunction during both ischemic and reperfusion phases.
  • Antioxidant therapy with SOD shows potential in mitigating PMN-induced cardiac damage.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...